Trial Search Results

Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma

Impact on contrast dose or total volume of contrast required to effectively treat the targeted tumor.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University


  • Device: dTA/dBA C-arm fluoroscopy system with Dyna CT
  • Procedure: DSA arteriogram- hepatic arteries
  • Procedure: CO2 aortogram




Inclusion Criteria:

   1. Patients must be affected by HCC

   2. Patients must have diminished renal function (GFR<60 ml/min/1.73m^2)

   3. Patients must be 18 years old or older

   4. Patients must have received an abdominal CT, PET/CT scan or MRI, completed prior to
   the TACE procedure.

   5. Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria:

   1. Subjects under the age of 18

   2. Patients currently on dialysis

   3. Pregnant women

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305